FINE-HEART Pooled Analysis
Dr. Pabon discusses new data from ACC 2025 showing that finerenone significantly lowers new-onset AF risk across the cardio-kidney-metabolic spectrum.
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Jonathan Cunningham, MD
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
John Ostrominski
Gautam Nayak, MD
